Titelaufnahme

Titel
Improving environmental protection in EU pharmaceutical legislation : recommendations for reducing adverse environmental impacts from human pharmaceuticals / by Daniela Gildemeister, Annika Buck, Arne Hein; Ines Rönnefahrt, Ina Ebert, Małgorzata Dębiak (German Environment Agency/Umweltbundesamt, DessauRoßlau) ; on behalf of the German Environment Agency ; publisher: Umweltbundesamt ; responsible unit: Section IV 2.2 Pharmaceuticals
VerfasserGildemeister, Daniela ; Buck, Annika ; Hein, Arne ; Rönnefahrt, Ines ; Ebert, Ina ; Debiak, Malgorzata
KörperschaftDeutschland
ErschienenDessau-Roßlau : Umweltbundesamt, October 2022
Umfang1 Online-Ressource (23 Seiten, 1,48 MB) : Illustrationen, Diagramme
SpracheEnglisch
SerieScientific opinion paper ; October 2022
URNurn:nbn:de:gbv:3:2-919049 
Zugriffsbeschränkung
 Das Dokument ist frei verfügbar
Dateien
Improving environmental protection in EU pharmaceutical legislation [1.48 mb]
Links
Nachweis
Kein Nachweis verfügbar
Klassifikation
Keywords
In preparation of the revision of Directive 2001/83/ EC and Regulation (EC) No 726/2004 the German Environment Agency (⁠UBA⁠) proposes legal changes to reduce pharmaceutical residues in the environment. The proposals are based on UBA’s experiences as competent authority for the environmental risk assessment (ERA) of pharmaceuticals. Our overall aim is to ensure a comprehensive risk management system without compromising availability of medicines for patients. In this context we consider the recent EU strategy on pharmaceuticals and initiatives in connection with EU`s Green Deal particularly the Zero Pollution Ambition and the one substance one assessment approach.